BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34374130)

  • 1. Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability.
    Jin M; Kong L; Han Y; Zhang S
    Phytother Res; 2021 Oct; 35(10):5823-5837. PubMed ID: 34374130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
    Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
    Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis.
    Wu R; Mei X; Ye Y; Xue T; Wang J; Sun W; Lin C; Xue R; Zhang J; Xu D
    Pharmacol Res; 2019 Dec; 150():104454. PubMed ID: 31526871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
    Zheng X; Yang X; Lin J; Song F; Shao Y
    Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.
    Liao B; Liang H; Chen J; Liu Q; Zhang B; Chen X
    Tumour Biol; 2015 Dec; 36(12):9347-56. PubMed ID: 26108995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.
    Grbčić P; Tomljanović I; Klobučar M; Kraljević Pavelić S; Lučin K; Sedić M
    Biochem Biophys Res Commun; 2017 Jun; 487(4):782-788. PubMed ID: 28433634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1.
    Han L; Wang Y; Sun S
    Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma.
    Wang Z; Gu C; Wang X; Lang Y; Wu Y; Wu X; Zhu X; Wang K; Yang H
    Med Oncol; 2019 Oct; 36(12):97. PubMed ID: 31664534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma.
    Hu XY; Liang JY; Guo XJ; Liu L; Guo YB
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):146-53. PubMed ID: 25363523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curcumin combined with 5-FU promotes autophagy and down-regulates the expression of Yes-associated protein (YAP) in hepatocellular carcinoma cells].
    Wang X; Zhu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Oct; 37(10):917-922. PubMed ID: 34670669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma.
    Ma X; Qiu Y; Zhu L; Zhao Y; Lin Y; Ma D; Qin Z; Sun C; Shen X; Li T; Han L
    J Mol Med (Berl); 2020 Feb; 98(2):221-232. PubMed ID: 31872284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
    Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
    Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
    Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
    Dong C; Zhao B; Long F; Liu Y; Liu Z; Li S; Yang X; Sun D; Wang H; Liu Q; Liang R; Li Y; Gao Z; Shao S; Miao QR; Wang L
    Oncotarget; 2016 Feb; 7(8):8850-65. PubMed ID: 26840457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Orai1-mediated Ca
    Tang BD; Xia X; Lv XF; Yu BX; Yuan JN; Mai XY; Shang JY; Zhou JG; Liang SJ; Pang RP
    J Cell Mol Med; 2017 May; 21(5):904-915. PubMed ID: 27878958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.